| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 06/14/2000 | EP1007561A2 Novel conjugates of opioids and endogenous carriers |
| 06/14/2000 | EP1007506A2 Compositions and methods for reversibly increasing permeability of biomembranes |
| 06/14/2000 | EP1007504A1 Sterilized 5-aminolevulinic acid |
| 06/14/2000 | EP1007181A1 Process for the selection of particles of a preselected size from a particulate pharmaceutical product |
| 06/14/2000 | EP1007106A1 Combinatorial library |
| 06/14/2000 | EP1007105A2 Method for producing contrast agents largely free of side-effects |
| 06/14/2000 | EP1007104A1 Improvements in or relating to contrast agents |
| 06/14/2000 | EP1007103A2 Process for preparation of lyophilised contrast agents |
| 06/14/2000 | EP1007102A1 Process for preparing contrast agents |
| 06/14/2000 | EP1007101A2 Improvements in or relating to diagnostic/therapeutic agents |
| 06/14/2000 | EP1007100A2 Improvements in or relating to contrast agents |
| 06/14/2000 | CN1256634A MRI contrast media recognizing minor environmental changes |
| 06/13/2000 | US6075134 Glycoconjugates and methods |
| 06/13/2000 | US6074873 Nucleic acids encoding NL-3 |
| 06/13/2000 | US6074666 Liposome compositions of porphyrin photosensitizers |
| 06/13/2000 | US6074625 Using complex of boron isotope |
| 06/13/2000 | CA2000979C Specific ligands of receptors of oestrogen and progesterone steroidal hormones, use and synthetic intermediates |
| 06/08/2000 | WO2000033068A1 Therapeutic and diagnostic tools for impaired glucose tolerance conditions |
| 06/08/2000 | WO2000033065A1 In vivo biosensor apparatus and method of use |
| 06/08/2000 | WO2000032822A1 Methods for introducing heterologous cells into fish |
| 06/08/2000 | WO2000032600A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives |
| 06/08/2000 | WO2000032240A2 Radioconjugation of internalizing antibodies |
| 06/08/2000 | WO2000012536A3 Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides |
| 06/08/2000 | WO1999064572A3 Poly(adp-ribose) polymerase gene |
| 06/08/2000 | WO1999024076A9 Salicylate derivatized therapeutic and diagnostic agents |
| 06/08/2000 | CA2352568A1 Methods for introducing heterologous cells into fish |
| 06/08/2000 | CA2342621A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives |
| 06/07/2000 | EP1006194A2 C-erbB-2 external domain: GP75 |
| 06/07/2000 | EP1005391A1 Process for preparation of vesicles |
| 06/07/2000 | EP1005369A2 Use of a texaphyrin in the preparation of a medicament for use in ocular diagnosis and therapy |
| 06/07/2000 | EP1005335A1 Process for preparing a reactive pharmaceutical product for the detection of gastrointestinal disorder caused by bacteria in the gastrointestinal superior tract |
| 06/07/2000 | EP1005327A1 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 06/06/2000 | US6072069 Biodegradable nonionic contrast media |
| 06/06/2000 | US6072038 Conjugates of texaphyrins |
| 06/06/2000 | US6071697 Method for testing the differentiation status in pancreatic cells of a mammal |
| 06/06/2000 | US6071496 Biodegradable; medical diagnosis |
| 06/06/2000 | US6071495 Targeted gas and gaseous precursor-filled liposomes |
| 06/06/2000 | US6071494 Lipid, protein or polymer and a gas or gaseous precursor, in combination with a renal vasodilator. |
| 06/06/2000 | US6071491 Administering an antibody against cell ghosts, wherein the antibody is specific to an intracellular antigen not present on the cell surface of normal or neoplastic cells, and wherein the antibody is labeled |
| 06/06/2000 | CA2060182C Resuspendable coated magnetic particles and stable magnetic particle suspensions |
| 06/06/2000 | CA1341017C Use of growth hormone releasing factor for improving mental function |
| 06/02/2000 | WO2000031542A1 Detection of t cell stimulating tumor antigens |
| 06/02/2000 | WO2000030688A2 Amphipatic polycarboxylic chelates and complexes with paramagnetic metals as mri contrast agents |
| 06/02/2000 | WO2000014236A3 Grf analogs with increased biological potency |
| 05/31/2000 | EP1003774A1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6 |
| 05/31/2000 | EP1003501A1 Means of ascertaining an individual's risk profile for atherosclerotic disease |
| 05/31/2000 | EP1003458A2 Liver function test |
| 05/31/2000 | EP0983105A4 Method of removing thrombosis in fistulae |
| 05/31/2000 | EP0861093B1 Non-invasive Detection of the Integration of a Transgene in Mammals |
| 05/31/2000 | EP0521880B2 Contrast medium containing a non-ionic contrast agent and sodium and calcium salts |
| 05/30/2000 | US6069140 Pharmaceutical compositions comprising texaphyrins |
| 05/30/2000 | US6069127 Human infant formula containing a glycoprotein specific for binding to the human mac-2 (macrophage antigen) lectin; to prevent infections |
| 05/30/2000 | US6069001 Nucleotide sequence; for use in diagnosis of cancer and melanoma; for use in human leukocyte antigen typing for grafts and transplants |
| 05/30/2000 | US6068857 Microparticles containing active ingredients, agents containing these microparticles, their use for ultrasound-controlled release of active ingredients, as well as a process for their production |
| 05/30/2000 | US6068831 Pseudopolyrotaxanes |
| 05/30/2000 | US6068830 In vivo method for imaging breast and ovarian cancers in non-prostatic tissue of a patient |
| 05/30/2000 | US6068829 Relates generally to the fields of molecular medicine and drug delivery and, more specifically, to a method of in vivo panning for identifying a molecule that homes to a specific organ |
| 05/30/2000 | US6068600 Use of hollow microcapsules |
| 05/25/2000 | WO2000029372A1 Preparation of 5-amino-isophthalamides |
| 05/25/2000 | WO2000029206A1 Monodisperse preparations useful with implanted devices |
| 05/25/2000 | WO2000028971A1 Nano-emulsion of 5-aminolevulinic acid |
| 05/25/2000 | WO2000028920A1 Therapeutic use of polymers |
| 05/25/2000 | WO2000015266A3 Radio-contrast agents |
| 05/24/2000 | EP1001985A1 Kringle domains 1-5 of plasminogen, capable of modulating angiogenesis in vivo |
| 05/24/2000 | EP1001816A1 Perfluorinated-ether compositions as diagnostic contrast agents |
| 05/24/2000 | EP0686046B1 Contrast agents |
| 05/24/2000 | CN1254346A Calcitonin receptor-binding peptides |
| 05/24/2000 | CN1254339A Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 05/23/2000 | US6066778 Rodent genetically engineered to be defective in blood coagulation; models for evaluating potentially useful anticoagulant agents |
| 05/23/2000 | US6066447 Including nucleoside dimers with modified backbones; for viricides and antisense agents |
| 05/23/2000 | US6066310 Diagnostic and therapeutic method for tumor using radiolabeled avidin |
| 05/23/2000 | CA2079448C Lanthanide chelate-conjugated oligonucleotides |
| 05/18/2000 | WO2000028598A1 Methods for identification and verification |
| 05/18/2000 | WO2000028554A1 Products and methods for brachytherapy |
| 05/18/2000 | WO2000028025A1 Pholasin |
| 05/18/2000 | WO2000027436A1 Functionalized nanocrystals as visual tissue-specific imaging agents, and methods for fluorescence imaging |
| 05/18/2000 | DE19852245A1 5-Aminolävulinsäure-Nanoemulsion 5-aminolevulinic acid nanoemulsions |
| 05/18/2000 | CA2350339A1 Pholasin |
| 05/18/2000 | CA2345620A1 Products and methods for brachytherapy |
| 05/17/2000 | EP1000930A2 Tachykinin antagonists |
| 05/17/2000 | EP1000367A1 Contrast agent-enhanced magnetic resonance imaging of tissue perfusion |
| 05/17/2000 | EP0999849A1 Therapeutic agent for the treatment of septicaemia, its preparation and use |
| 05/17/2000 | CN1253507A Acid-labile and enzymatically divisible dye structure for diagnosis with near infrared light and for therapy |
| 05/16/2000 | US6063400 Targeted liposomal constructs for diagnostic and therapeutic uses |
| 05/16/2000 | US6063362 An aqueous suspension of microspheres consisting of three phases: a shell of biocompatible, amphiphilic material, a liquid or solid hydrophobic barrier formed by condensation of hydrophobic compound, a gaseous phase enclosed by the shell |
| 05/16/2000 | US6063361 Administering to a patient at least one cascade polymer complex and subjecting the patient to a radiology diagnosis |
| 05/16/2000 | US6063360 Free radicals comprising benzodithiole derivatives |
| 05/16/2000 | US6063359 Method for determining oncogenic activity of a substance |
| 05/16/2000 | CA2090033C Conjugated moieties for chelating paramagnetic metals |
| 05/16/2000 | CA2081637C Rhenium and technetium complexes containing a hypoxia-localizing moiety |
| 05/11/2000 | WO2000026360A1 Compounds and methods for modulating claudin-mediated functions |
| 05/11/2000 | WO2000026353A1 Cyclic peptide ligands that target urokinase plasminogen activator receptor, their pharmaceutical compositions and use |
| 05/11/2000 | WO2000026248A2 Tuberculosis diagnostic test |
| 05/11/2000 | WO2000026179A1 Biodegradable nonionic contrast media |
| 05/11/2000 | WO2000025829A2 Radiodense compositions |
| 05/11/2000 | WO2000025828A1 Hyperpolarized helium-3 microbubble gas entrapment methods |
| 05/11/2000 | WO2000025819A1 Enhanced radiation therapy |
| 05/11/2000 | WO2000025671A1 Manganese compositions and methods for mri |
| 05/11/2000 | WO2000025665A1 Method for improved imaging and photodynamic therapy |
| 05/11/2000 | WO2000007565A3 Methods of ophthalmic administration |